IPHA logo

Innate Pharma S.A. (IPHA)

Profile

Full Name

Innate Pharma S.A.

Ticker

NASDAQ: IPHA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

October 17, 2019

Indexes

Not included

Website

https://www.innate-pharma.com

Employees

181

Key Details

Price

$2.05(-1.44%)

Market cap

$188.94M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$13.65M(-75.67% YoY)

Annual EPS

-$0.66(-578.11% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.05
    IPHA price is $2.05

    30-Day Relative Volume

    5.54
    IPHA 30-day relative volume is 5.54

    Price Performance

    Price Most recent change

    -1.44%
    IPHA price was down -1.44% on Sep 17, 2025

    Price YTD change

    +11.41%
    IPHA price is up +11.41% since January 1st

    Price 1-year change

    -7.24%
    IPHA price is down -7.24% year-on-year

    Price 3-year change

    -33.22%
    IPHA price is down -33.22% over the past 3 years

    Price Range

    Price All-time high

    $11.95
    IPHA price is currently -82.85% below its historical high of $11.95

    Price 3-year low

    $1.29
    IPHA price is currently +58.91% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $188.94M
    IPHA market capitalization is $188.94 million

    Market cap 3-year change

    -22.97%
    IPHA market capitalization is down -22.97% over the past 3 years

    Market cap All-time high

    $646.81M
    IPHA market capitalization is currently -70.79% below its historical high of $646.81 million

    Market cap sector rank

    49.75%
    IPHA market capitalization is higher than 49.75% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.86%
    IPHA shares outstanding is up +13.86% year-on-year

    Shares Outstanding 3-Year Change

    +15.36%
    IPHA shares outstanding is up +15.36% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.21
    IPHA beta is 0.21

    200-day SMA

    $1.99
    IPHA price is currently +2.97% above its 200-day simple moving average

    50-day SMA

    $2.06
    IPHA price is currently -0.30% below its 50-day simple moving average

    RSI

    46.90
    IPHA 14-day relative strength index is 46.90

    Volume

    5.54
    IPHA 30-day relative volume is 5.54

    ATR

    $0.13
    IPHA average true range is $0.13

    10-day Historical Volatility

    33.81%
    IPHA 10-day historical volatility is 33.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $13.65M
    IPHA annual revenue is $13.65 million

    Revenue Analysts estimate

    $72.38M
    IPHA annual revenue is currently -81.14% lower than the consensus analysts' forecast

    Revenue 1-year change

    -75.67%
    IPHA annual revenue is down -75.67% year-on-year

    Revenue Sector rank

    50.58%
    IPHA annual revenue is higher than 50.58% of companies in Healthcare sector

    EPS

    EPS

    -$0.66
    IPHA annual earnings per share is -$0.66

    EPS Analysts estimate

    -$0.78
    IPHA annual earnings per share is currently -15.30% lower than the consensus analysts' forecast

    EPS 1-year change

    -578.11%
    IPHA annual earnings per share is down -578.11% year-on-year

    EPS Sector rank

    59.11%
    IPHA annual earnings per share is higher than 59.11% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    IPHA annual gross profit is $0.00

    Gross margin

    0.00%
    IPHA annual gross profit margin is 0.00%

    Operating profit

    -$63.93M
    IPHA annual operating income is -$63.93 million

    Operating margin

    -468.22%
    IPHA annual operating profit margin is -468.22%

    Net income

    -$53.51M
    IPHA annual net profit is -$53.51 million

    Net margin

    -391.94%
    IPHA annual net profit margin is -391.94%

    Expenses

    Total expenses

    $67.17M
    IPHA annual total expenses is $67.17 million

    Operating expenses

    $63.93M
    IPHA annual total operating expenses is $63.93 million

    Cost of goods sold

    -
    IPHA annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $0.00
    IPHA annual SGA is $0.00

    Depreciation and amortization

    $2.15M
    IPHA annual depreciation & amortization is $2.15 million

    Interest expense

    $0.00
    IPHA annual interest expense is $0.00

    Income tax

    -$8.10M
    IPHA annual income tax is -$8.10 million

    EBIT & EBITDA

    EBIT

    -$63.93M
    IPHA annual earnings before interest & taxes is -$63.93 million

    EBITDA

    -$61.78M
    IPHA annual EBITDA is -$61.78 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $115.00M
    IPHA annual total assets is $115.00 million

    Non current assets

    $26.34M
    IPHA annual long term assets is $26.34 million

    Current assets

    $88.79M
    IPHA annual total current assets is $88.79 million

    Cash and cash equivalents

    $83.64M
    IPHA annual cash & cash equivalents is $83.64 million

    Accounts receivable

    $673.10K
    IPHA annual accounts receivable is $673.10 thousand

    Inventory

    $0.00
    IPHA annual inventory is $0.00

    Liabilities

    Total liabilities

    $105.85M
    IPHA annual total liabilities is $105.85 million

    Long term liabilities

    $71.70M
    IPHA annual total long term liabilities is $71.70 million

    Current liabilities

    $34.15M
    IPHA annual total current liabilities is $34.15 million

    Accounts payable

    $8.20M
    IPHA annual accounts payable is $8.20 million

    Debt

    Total debt

    $32.10M
    IPHA annual total debt is $32.10 million

    Total debt 1-year change

    -27.17%
    IPHA annual total debt is down -27.17% year-on-year

    Long term debt

    $23.08M
    IPHA annual long term debt is $23.08 million

    Short term debt

    $9.02M
    IPHA annual short term debt is $9.02 million

    Equity & Capital

    Shareholders equity

    $9.15M
    IPHA annual stockholders equity is $9.15 million

    Book value

    $9.15M
    IPHA annual book value is $9.15 million

    Retained earnings

    -$400.08M
    IPHA annual retained earnings is -$400.08 million

    Working capital

    $54.63M
    IPHA annual working capital is $54.63 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$7.46M
    IPHA annual cash flow from operations is -$7.46 million

    Cash from operations 1-year change

    +78.81%
    IPHA annual cash flow from operations is up +78.81% year-on-year

    Cash from investing

    $9.95M
    IPHA annual cash flow from investing activities is $9.95 million

    Cash from investing 1-year change

    -55.38%
    IPHA annual cash flow from investing activities is down -55.38% year-on-year

    Cash from financing

    -$6.50M
    IPHA annual cash flow from financing activities is -$6.50 million

    Cash from financing 1-year change

    -205.75%
    IPHA annual cash flow from financing activities is down -205.75% year-on-year

    CAPEX

    CAPEX

    $422.90K
    IPHA annual capital expenditures is $422.90 thousand

    CAPEX 1-year change

    -83.38%
    IPHA annual capital expenditures is down -83.38% year-on-year

    Free Cash Flow

    Free cash flow

    -$7.88M
    IPHA annual free cash flow is -$7.88 million

    Free cash flow 1-year change

    +79.12%
    IPHA annual free cash flow is up +79.12% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    0.00%
    IPHA annual gross profit margin is 0.00%

    Operating margin

    -468.22%
    IPHA annual operating profit margin is -468.22%

    Net margin

    -391.94%
    IPHA annual net profit margin is -391.94%

    ROA & ROE

    ROA

    -34.69%
    IPHA annual return on assets is -34.69%

    ROE

    -160.99%
    IPHA annual return on equity is -160.99%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IPHA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IPHA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    20.55
    IPHA price to book ratio is 20.55

    PB ratio Sector rank

    94.87%
    IPHA price to book ratio is higher than 94.87% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    IPHA price to sales ratio value is unknown

    PS ratio Sector rank

    -
    IPHA price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $152.10M
    IPHA enterprise value is $152.10 million

    Enterprise value Sector rank

    52.54%
    IPHA enterprise value is higher than 52.54% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    IPHA EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    IPHA EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.60
    IPHA annual current ratio is 2.60

    Quick ratio

    2.60
    IPHA annual quick ratio is 2.60

    Leverage

    Debt to equity

    3.51
    IPHA annual debt to equity ratio is 3.51

    Interest coverage ratio

    -
    IPHA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    IPHA piotroski f-score value is unknown

    Altman Z-Score

    -4.95
    IPHA altman z-score is -4.95

    Analyst ratings

    Recent major analysts updates

    Apr 24, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 HC Wainwright & Co.
    Buy
    Feb 6, 25 HC Wainwright & Co.
    Buy
    Jan 17, 25 HC Wainwright & Co.
    Buy
    Dec 9, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Nov 12, 24 HC Wainwright & Co.
    Buy
    Sep 13, 24 HC Wainwright & Co.
    Buy
    Jun 12, 24 HC Wainwright & Co.
    Buy
    May 15, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with IPHA included

    Growing Shares Outstanding
    Earnings today
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Earnings this week
    Biotech Companies
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Innate Pharma S.A.?
    • Does Innate Pharma S.A. pay dividends?
    • What sector is Innate Pharma S.A. in?
    • What industry is Innate Pharma S.A. in?
    • What country is Innate Pharma S.A. based in?
    • When did Innate Pharma S.A. go public?
    • Is Innate Pharma S.A. in the S&P 500?
    • Is Innate Pharma S.A. in the NASDAQ 100?
    • Is Innate Pharma S.A. in the Dow Jones?
    • When was Innate Pharma S.A.'s last earnings report?
    • When does Innate Pharma S.A. report earnings?

    What is the ticker symbol for Innate Pharma S.A.?

    The ticker symbol for Innate Pharma S.A. is NASDAQ:IPHA

    Does Innate Pharma S.A. pay dividends?

    No, Innate Pharma S.A. does not pay dividends

    What sector is Innate Pharma S.A. in?

    Innate Pharma S.A. is in the Healthcare sector

    What industry is Innate Pharma S.A. in?

    Innate Pharma S.A. is in the Biotechnology industry

    What country is Innate Pharma S.A. based in?

    Innate Pharma S.A. is headquartered in France

    When did Innate Pharma S.A. go public?

    Innate Pharma S.A.'s initial public offering (IPO) was on October 17, 2019

    Is Innate Pharma S.A. in the S&P 500?

    No, Innate Pharma S.A. is not included in the S&P 500 index

    Is Innate Pharma S.A. in the NASDAQ 100?

    No, Innate Pharma S.A. is not included in the NASDAQ 100 index

    Is Innate Pharma S.A. in the Dow Jones?

    No, Innate Pharma S.A. is not included in the Dow Jones index

    When was Innate Pharma S.A.'s last earnings report?

    Innate Pharma S.A.'s most recent earnings report was on September 17, 2025

    When does Innate Pharma S.A. report earnings?

    The date for Innate Pharma S.A.'s next earnings report has not been announced yet
    On this page